MEMORANDUM - WHO
MEMORANDUM November 30, 2012 TO: World Health Organization Expert Committee on the Selection and Use of Essential Medicines FROM: PATH, on behalf of the Chlorhexidine Working Group RE: Change requested in the next World Health Organization Model List of Essential Medicines for Children from the current listing of Chlorhexidine Solution: 5%
Download MEMORANDUM - WHO
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
stability testing for applications for variations to a ...
gmpeye.co.krGuideline on Stability Testing for Applications for Variations to a Marketing Authorisation GE034A ggmmppeeyyee www.gmpeye.co.kr 2 GUIDELINE ON STABILITY TESTING FOR APPLICATIONS FOR
IPEC Stability Subcommittee
ipec-europe.orgPage 8 of 14 In selecting the packaging for conducting the stability study, the same care and : :
BRACKETING AND MATRIXING DESIGNS FOR STABILITY …
www.ich.orgBRACKETING AND MATRIXING DESIGNS FOR STABILITY TESTING OF NEW DRUG SUBSTANCES AND PRODUCTS 1. INTRODUCTION 1.1 Objectives of the Guideline This guideline is intended to address recommendations on the application of bracketing and matrixing to stability studies conducted in accordance with
ICH Q5C Stability testing of Biotechnological / Biological ...
www.ich.org5 ICH Q5C - Stability testing of Biotechnological / Biological products ICH guidelines on stability (II) • Q1D –Bracketing and matrixing designs for Stability …
32 1.4 Stability Workshpo ICH Q1D C - IKEV
www.ikev.orgICHQ1D C 42 1.4 ICH Q1D Guideline Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products ICH Step 4 Comments for its application